Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study

Enginoev S.T.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Chernov I.I.

Federal Center for Cardiovascular Surgery

Komarov R.N.

Sechenov First Moscow State Medical University

ORCID: 0000-0002-3904-6415

Sinelnikov Yu.S.

Sukhanov Federal Center for Cardiovascular Surgery

Semagin A.P.

Polyakov Samara Regional Clinical Cardiology Dispensary

Arutyunayan V.B.

Sukhanov Federal Center of Cardiovascular Surgery

Chragyan V.A.

Sukhanov Federal Center of Cardiovascular Surgery

Kadyraliyev B.K.

Sechenov First Moscow State Medical University

Pisaryuk A.S.

Peoples’ Friendship University of Russia

Ismailbaev A.M.

Sechenov First Moscow State Medical University

ORCID: 0000-0001-8545-3276

Kuznetsov D.V.

Polyakov Samara Regional Clinical Cardiology Dispensary

Zybin A.A.

Polyakov Samara Regional Clinical Cardiology Dispensary

Dzandukoeva P.Kh.

Astrakhan State Medical University

Tlisov B.M.

Sechenov First Moscow State Medical University

ORCID: 0000-0003-4094-8771

Abdurakhmanov A.A.

Astrakhan State Medical University

Tarasov D.G.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study

Authors:

Enginoev S.T., Chernov I.I., Komarov R.N., Sinelnikov Yu.S., Semagin A.P., Arutyunayan V.B., Chragyan V.A., Kadyraliyev B.K., Pisaryuk A.S., Ismailbaev A.M., Kuznetsov D.V., Zybin A.A., Dzandukoeva P.Kh., Tlisov B.M., Abdurakhmanov A.A., Tarasov D.G.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6): 578‑585

DOI: 10.17116/kardio202215061578

Downloaded: 33

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Enginoev ST, Chernov II, Komarov RN, et al. . Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):578‑585. (In Russ.)
https://doi.org/10.17116/kardio202215061578

Close metadata

OBJECTIVE

To determine the incidence and risk factors of infective endocarditis (IE) after aortic valve neocuspidization.

MATERIAL AND METHODS

The study included 251 patients (116 men and 135 women) with aortic valve disease who underwent aortic valve neocuspidization in 4 hospitals between 2016 and 2019. The median follow-up period was 24 [17; 32] months.

RESULTS

IE occurred in 7 patients (2.8%) after aortic valve neocuspidization. Three-year freedom from IE was 96.6%, 3-year freedom from redo surgery — 94.6%, 3-year overall survival — 90.6%. Risk factors of IE were surgery for active IE (relative risk 16.5; 95% CI 2.85—95.54, p=0.002) and percutaneous coronary intervention for coronary artery disease (RR 11.6; 95% CI 2.24—60.14, p=0.003).

CONCLUSION

Aortic valve neocuspidization can potentially reduce the incidence of infectious complications in certain groups of patients. Further prospective multiple-center studies are needed to confirm this hypothesis.

Keywords:

aortic valve neocuspidization

Ozaki procedure

outcomes

infective endocarditis

incidence

risk factors

Authors:

Enginoev S.T.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Chernov I.I.

Federal Center for Cardiovascular Surgery

Komarov R.N.

Sechenov First Moscow State Medical University

ORCID: 0000-0002-3904-6415

Sinelnikov Yu.S.

Sukhanov Federal Center for Cardiovascular Surgery

Semagin A.P.

Polyakov Samara Regional Clinical Cardiology Dispensary

Arutyunayan V.B.

Sukhanov Federal Center of Cardiovascular Surgery

Chragyan V.A.

Sukhanov Federal Center of Cardiovascular Surgery

Kadyraliyev B.K.

Sechenov First Moscow State Medical University

Pisaryuk A.S.

Peoples’ Friendship University of Russia

Ismailbaev A.M.

Sechenov First Moscow State Medical University

ORCID: 0000-0001-8545-3276

Kuznetsov D.V.

Polyakov Samara Regional Clinical Cardiology Dispensary

Zybin A.A.

Polyakov Samara Regional Clinical Cardiology Dispensary

Dzandukoeva P.Kh.

Astrakhan State Medical University

Tlisov B.M.

Sechenov First Moscow State Medical University

ORCID: 0000-0003-4094-8771

Abdurakhmanov A.A.

Astrakhan State Medical University

Tarasov D.G.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Received:

19.01.2022

Accepted:

13.06.2022

List of references:

Cahill TJ, Prendergast BD. Risk of infective endocarditis after left-sided surgical valve replacement. Eur Heart J. 2018;39:2676-2678. https://doi.org/10.1093/eurheartj/ehy143
Østergaard L, Valeur N, Ihlemann N, Smerup MH, Bundgaard H, Gislason G, et al. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J. 2018;39:2668-2675. https://doi.org/10.1093/eurheartj/ehy153
Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586-595. https://doi.org/10.1093/eurheartj/ehx655
Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement. Circulation. 2017;136:329-331. https://doi.org/10.1161/CIRCULATIONAHA.117.028783
Østergaard L, Valeur N, Ihlemann N, Bundgaard H, Gislason G, Torp-Pedersen C, et al. Incidence of infective endocarditis among patients considered at high risk. Eur Heart J. 2018;39:623-629. https://doi.org/10.1093/eurheartj/ehx682
Bockeria LA. (ed.). Cardiovascular Surgery — 2019. M.: A.N. Bakulev National Medical Research Center of Cardiovascular Surgery; 2020. (In Russ.).
Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Takatoh M, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014;147:301-306. https://doi.org/10.1016/j.jtcvs.2012.11.012
Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Kiyohara N. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2018;155:2379-2387. https://doi.org/10.1016/j.jtcvs.2018.01.087
Arutyunyan V, Chernov I, Komarov R, Sinelnikov Y, Kadyraliev B, Enginoev S, et al. Immediate outcomes of aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium: A multicenter study. Brazilian J Cardiovasc Surg. 2020;35:241-248. https://doi.org/10.21470/1678-9741-2020-0019
Chernov II, Enginoev ST, Komarov RN, et al. Short-term outcomes of Ozaki procedure: a multicenter study. Russian Journal of Cardiology. 2020;25(S4):4157. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4157
Iida Y, Sawa S, Fujii S, Shimizu H. Aortic valve neocuspidization in patients under 65 years old. Gen Thorac Cardiovasc Surg. 2020;68:780-784. https://doi.org/10.1007/s11748-020-01302-9
Akiyama S, Iida Y, Shimura K, Fujii S, Shimizu H, Sawa S. Midterm outcome of aortic valve neocuspidization for aortic valve stenosis with small annulus. Gen Thorac Cardiovasc Surg. 2020;68:762-767. https://doi.org/10.1007/s11748-020-01299-1
Benedetto U, Sinha S, Dimagli A, Dixon L, Stoica S, Cocomello L, et al. Aortic valve neocuspidization with autologous pericardium in adult patients: UK experience and meta-analytic comparison with other aortic valve substitutes. Eur J Cardio-Thoracic Surg. 2021;60(1):34-36. https://doi.org/10.1093/ejcts/ezaa472
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European. Eur Heart J. 2015;36:3075-3128. https://doi.org/10.1093/eurheartj/ehv319
Sá MP, Chernov I, Marchenko A, chagyan V, Komarov R, Askadinov M, et al. Aortic Valve Neocuspidization (Ozaki Procedure) in Patients with Small Aortic Annulus (≤21mm): A Multicenter Study. Struct Hear. 2020;4(5):413-419. https://doi.org/10.1080/24748706.2020.1792595
d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515-3522. https://doi.org/10.1093/eurheartj/ehw229
Wang A, Athan E, Pappas PA, Fowler VGJ, Olaison L, Paré C et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354-1361. https://doi.org/10.1001/jama.297.12.1354
Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121:1141-1152. https://doi.org/10.1161/CIRCULATIONAHA.108.773598
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75-81. https://doi.org/10.1001/jama.288.1.75
Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Bärwolf C, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91:571-575. https://doi.org/10.1136/hrt.2003.032128
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222-3232. https://doi.org/10.1093/eurheartj/ehz620
Moiseev VS, Kobalava ZD, Pisaryuk AS et al. Infective endocarditis in Moscow General Hospital: Clinical characteristics and outcomes (single-center 7-year experience). Kardiologiya. 2018;58:66-75. (In Russ.). https://doi.org/10.18087/cardio.2018.12.10192
Duran CM, Gallo R, Kumar N. Aortic valve replacement with autologous pericardium: surgical technique. J Card Surg. 1995;10:1-9. https://doi.org/10.1111/j.1540-8191.1995.tb00582.x
Reuthebuch O, Koechlin L, Schurr U, Grapow M, Fassl J, Eckstein FS. Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique. Swiss Med Wkly. 2018;148:w14591. https://doi.org/10.4414/smw.2018.14591
Komarov R, Kurasov N, Ismailbaev A, Tlisov B, Danachev A, Simonyan A, et al. Aortic homograft implantation after Ozaki procedure: Case report. Int J Surg Case Rep. 2021;81:105782. https://doi.org/10.1016/j.ijscr.2021.105782
Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 1988;2:340-346.
Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:57-61. https://doi.org/10.1016/s0003-4975(98)01110-2
Geraci JE, Dale AJ, Mcgoon DC. Bacterial endocarditis and endarteritis following cardiac operations. Wis Med J. 1963;62:302-315.
Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation. 1984;69:223-232. https://doi.org/10.1161/01.cir.69.2.223
Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg. 1994;108:207-214.
Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin orth Am. 1993;7:9-19.
Hyde JA, Darouiche RO, Costerton JW. Strategies for prophylaxis against prosthetic valve endocarditis: a review article. J Heart Valve Dis. 1998;7:316-326.

Close metadata